✦ LIBER ✦

Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease

✍ Scribed by Mika Shimoji; Li Zhang; Allen S. Mandir; Valina L. Dawson; Ted M. Dawson

Book ID: 116753302
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 342 KB
Volume: 134
Category: Article
ISSN: 0169-328X
DOI: 10.1016/j.molbrainres.2005.01.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protocol for the MPTP mouse model of Par

Protocol for the MPTP mouse model of Parkinson's disease

✍ Jackson-Lewis, Vernice; Przedborski, Serge 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 295 KB

Behavioral phenotyping of the MPTP mouse

Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

✍ Marco Sedelis; Rainer K.W Schwarting; Joseph P Huston 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 153 KB

The MPTP model of Parkinson's disease

✍ Richard Jay Smeyne; Vernice Jackson-Lewis 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Immunological changes in the MPTP-induce

Immunological changes in the MPTP-induced Parkinson's disease mouse model

✍ Katarzyna Bieganowska; Anna Członkowska; Andrzej Bidziński; Hanna Mierzewska; Ja 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Neuroprotective effects of echinacoside

Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease

✍ Xingchao Geng; Xuefei Tian; Pengfei Tu; Xiaoping Pu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 626 KB

Neuroprotective effects of (±)-kavain in

Neuroprotective effects of (±)-kavain in the MPTP mouse model of Parkinson's disease

✍ Nicole Schmidt; Boris Ferger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o